ISSN: 2706-8870

Volume 8, Number 2 (2023)

Year Launched: 2016

Journal Menu

■ About The Journal

■ Aims & Scope

■ Editorial Board

■ Article Processing Charge

■ Archive

Previous Issues

■ Volume 10, Number 3 (2025)

■ Volume 10, Number 2 (2025)

■ Volume 10, Number 1 (2025)

■ Volume 9, Number 5 (2024)

■ Volume 9, Number 4 (2024)

■ Volume 9, Number 3 (2024)

■ Volume 9, Number 2 (2024)

■ Volume 9, Number 1 (2024)

■ Volume 8, Number 6 (2023)

■ Volume 8, Number 5 (2023)

■ Volume 8, Number 4 (2023)

■ Volume 8, Number 3 (2023)

■ Volume 8, Number 2 (2023)

■ Volume 8, Number 1 (2023)

■ Volume 7, Number 6 (2022)

■ Volume 7, Number 5 (2022)

■ Volume 7, Number 4 (2022)

■ Volume 7, Number 3 (2022)

■ Volume 7, Number 2 (2022)

■ Volume 7, Number 1 (2022)

■ Volume 6, Number 6 (2021)

■ Volume 6, Number 5 (2021)

■ Volume 6, Number 4 (2021)

■ Volume 6, Number 3 (2021)

■ Volume 6, Number 2 (2021)

■ Volume 6, Number 1 (2021)

■ Volume 5, Number 6 (2020)

■ Volume 5, Number 5 (2020)

■ Volume 5, Number 4 (2020)

■ Volume 5, Number 3 (2020)

■ Volume 5, Number 2 (2020)

■ Volume 5, Number 1 (2020)

■ Volume 4, Number 6 (2019)

■ Volume 4, Number 5 (2019)

■ Volume 4, Number 4 (2019)

■ Volume 4, Number 3 (2019)

■ Volume 4, Number 2 (2019)

■ Volume 4, Number 1 (2019)

■ Volume 3, Number 3 (2018)

■ Volume 3, Number 2 (2018)

■ Volume 3, Number 1 (2018)

■ Volume 2, Number 3 (2017)

■ Volume 2, Number 2 (2017)

■ Volume 2, Number 1 (2017)

■ Volume 1, Number 2 (2016)

■ Volume 1, Number 1 (2016)

Rheumatic Manifestations in Graves Disease

Volume 8, Issue 2, April 2023 | PP. 168-171 | PDF (226 K) | Pub. Date: April 17, 2023
DOI: 10.54647/cm321059 112 Downloads 10861 Views

Author(s)

Tyler G.Chin, Ursanius College; Biology/Medical, United States

Alyxandra Soloway, Inspira Health Network- Rheumatology, United States

Joseph Colombo, Stephen Soloway , Rheumatology, United States

Stephen Soloway, Chairman, Department of Rheumatology, Inspra Health Network, United States

Abstract

Keywords
Graves’ Disease, Thyroid Eye Disease, Hyperthyroidism, Pretibial Myxedema, Autoimmune

Cite this paper
Tyler G.Chin, Alyxandra Soloway, Joseph Colombo, Stephen Soloway, Rheumatic Manifestations in Graves Disease , SCIREA Journal of Clinical Medicine. Volume 8, Issue 2, April 2023 | PP. 168-171. 10.54647/cm321059

References

[ 1 ]	Edmunds, M & Boelaert, K 2019, 'Knowledge of thyroid eye disease in Graves’ Disease patients with and without orbitopathy', Thyroid, vol. 29, no. 4, pp. 557-562. https://doi.org/10.1089/thy.2018.0665
[ 2 ]	Khong JJ, McNab A. Medical treatment in thyroid eye disease in 2020. Br J Ophthalmol. 2021 Mar;105(3):299-305. doi: 10.1136/bjophthalmol-2020-316051. Epub 2020 May 23. PMID: 32447327.
[ 3 ]	Wiersinga WM, Smit T, van der Gaag R, Koornneef L. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. J Endocrinol Invest. 1988 Sep;11(8):615-9. doi: 10.1007/BF03350193. PMID: 2907524.
[ 4 ]	Smith TJ, Hegedüs L. Graves' Disease. N Engl J Med. 2016 Oct 20;375(16):1552-1565. doi: 10.1056/NEJMra1510030. PMID: 27797318.
[ 5 ]	Yeung SJ, Habra MA, Chiu AC. Grave's disease. Medscape emedicine website. https://emedicine.medscape.com/article/120619-overview